This website contains promotional content and is intended for Healthcare Professionals

  1. Article
  2. Source: Campus Sanofi
  3. Jul 16, 2025

Development of Insulin

Author: Sanofi

Editorial Team

   
Development of insulin formulations and routes of delivery with more favorable pk characteristics
StrategiesAdvantagesLimitations
Intranasal insulinSignificantly faster onset and offset in action with potential to reduce residual insulin activity associated with pre-exercise meal bolus

  • Not widely available

  • Long-term safety is not clear

Continuous intraperitoneal insulin infusion

  • Faster onset and offset action

  • Improves HbA1c with less hypoglycemia

  • Invasive procedures

  • Carries risk of infection and immunogenicity

Intravenous (IV) CL insulin delivery models

  • Rapid delivery with no delay in absorption

  • Would bypass limitations of SC route

  • Invasive

  • Prone to complications such as infections, thrombosis

  • Less feasible for ambulatory use

MAT-BH-2200900/V1/Nov 2022  

Related